Company Bionoid Pharma Inc. Other OTC
Equities
BINP
US09076D1019
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices and Technologies
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -64.71% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -64.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Meyers
CEO | Chief Executive Officer | - | - |
Mark Goldhar
DFI | Director of Finance/CFO | 40 | - |
Wayne Cockburn
CHM | Chairman | 66 | 03-08-31 |
- | - | ||
Jenna Maman
SEC | Corporate Secretary | - | - |
Ariel Maman
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wayne Cockburn
CHM | Chairman | 66 | 03-08-31 |
Barinder Rasode
BRD | Director/Board Member | - | - |
Dennis Reich
BRD | Director/Board Member | - | - |
Jeff Meyers
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,994,610 | 96,719 ( 0.1791 %) | 0 | 0.1791 % |
Company contact information
Bionoid Pharma, Inc.
5480 Glen Erin Drive Unit 105
L5M 5R3, Mississauga
+800 784 7641
http://bionoidinc.comSector
1st Jan change | Capi. | |
---|---|---|
+7.70% | 219B | |
+6.16% | 183B | |
+11.29% | 132B | |
+24.01% | 106B | |
-2.66% | 62.09B | |
+4.81% | 50.88B | |
+11.23% | 50.8B | |
-0.76% | 40.64B | |
+25.67% | 31.59B |